![Katia Schlienger](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Katia Schlienger
Plus aucun poste en cours
Fortune : 1 032 $ au 31/05/2024
Provenance du réseau au premier degré de Katia Schlienger
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Biotechnology | 12 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Katia Schlienger via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal | |
INOTIV, INC. | Miscellaneous Commercial Services | Director/Board Member | |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
Diversey, Inc.
![]() Diversey, Inc. Household/Personal CareConsumer Non-Durables Diversey, Inc. engages in the provision of cleaning, sanitation, and maintenance products, systems, and services. The firm offers floor care, dilution control, kitchen care, infection prevention, fabric care, food and beverage production, building care, and personal care. The company was founded by August Koch and Herbert W. Kochs on August 4, 1923 and is headquartered in Fort Mill, NC. | Household/Personal Care | Director of Finance/CFO | |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Notre Dame | College/University | Undergraduate Degree | |
Merck KGAA Unsponsored ADR Facility | Corporate Officer/Principal | ||
CureVac SE
![]() CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Public Communications Contact | |
NOVARTIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal | |
Wayne State University (Michigan) | College/University | Doctorate Degree | |
Mars, Inc.
![]() Mars, Inc. Food: Specialty/CandyConsumer Non-Durables Mars, Inc. engages in the production of confectionery and animal food products. Its brands include M&M?s, Snickers, Twix, Milky Way, Dove, Pedigree, Whiskas, Extra, Skittles, Uncle Ben's, and Cocoavia. The company was founded by Franklin Clarence Mars in 1911 and is headquartered in McLean, VA. | Food: Specialty/Candy | Corporate Officer/Principal | |
MORPHOSYS AG | Biotechnology | Chief Tech/Sci/R&D Officer | |
Dunbar Capital Management LLC
![]() Dunbar Capital Management LLC Investment ManagersFinance Part of Dunbar Capital Investors LLC, Dunbar Capital Management LLC is a company based in Whippany, NJ. | Investment Managers | Corporate Officer/Principal | |
Goldman Sachs & Co. LLC
![]() Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Corporate Officer/Principal | |
Carson Group, Inc. (New York)
![]() Carson Group, Inc. (New York) Investment ManagersFinance Carson Group provides financial information services. The firm specializes in global shareholder research and related advisory services. The company was foundedd by David M. Geliebter and is headquartered in New York, NY. | Investment Managers | Corporate Officer/Principal | |
Sandoz International GmbH
![]() Sandoz International GmbH Pharmaceuticals: GenericHealth Technology Sandoz International GmbH develops and manufactures generic pharmaceuticals. It produces finished dosage forms of such off-patent drugs as diabetes treatment Glucophage, GERD drug Prilosec, and cholesterol. The company was founded in 1996 and is headquartered in Holzkirchen, Austria. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Alliant International University | College/University | Masters Business Admin | |
The Johns Hopkins University | College/University | Masters Business Admin | |
Vassar College | College/University | Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Freie Universität Berlin | College/University | Doctorate Degree | |
GAMIDA CELL LTD. | Pharmaceuticals: Major | Director of Finance/CFO | |
Columbia University Medical Center | College/University | Corporate Officer/Principal | |
Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
Daiichi Sankyo, Inc.
![]() Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Crescendo Biologics Ltd.
![]() Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Amgen NV
![]() Amgen NV Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen NV is a pharmaceutical company based in Diegem, Belgium. The Belgian company is focused on developing innovative therapies to address serious illnesses and improve the lives of patients. Amgen is committed to advancing scientific research and delivering high-quality medicines to patients worldwide. The CEO of the company is Gabor Sztaniszlav. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ibmec Business School | College/University | Masters Business Admin | |
University of Antwerp | College/University | Graduate Degree | |
Hookipa Biotech AG
![]() Hookipa Biotech AG Medical SpecialtiesHealth Technology Hookipa Biotech AG develops new generation prophylactic and therapeutic vaccines. The firm’s Vaxwave technology is a novel immunotherapy platform using a replication-defective viral vector for the prevention and treatment of cancer and infectious diseases. The company was founded by Lukas Flatz, Andreas Bergthaler, Rolf M. Zinkernagel and Daniel Pinschewer in July 2011 and is headquartered in Vienna, Austria. | Medical Specialties | Director/Board Member Director/Board Member | |
ACTINIUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Investor Relations Contact | |
NASDAQ
![]() NASDAQ Investment Banks/BrokersFinance Part of Nasdaq, Inc., NASDAQ is a stock exchange. | Investment Banks/Brokers | Corporate Officer/Principal | |
School of International Service | College/University | Undergraduate Degree | |
ENTERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ESCP Europe | College/University | Graduate Degree | |
RELAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Tango Therapeutics Sub, Inc.
![]() Tango Therapeutics Sub, Inc. BiotechnologyHealth Technology Tango Therapeutics, Inc. develops transformational new drugs for cancer patients. The company was founded by Alan Ashworth, Jos? Baselga, Levi Garraway, Timothy K. Lu, Antoni Ribas and William G. Kaelin, Jr. in 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Celsius Therapeutics, Inc.
![]() Celsius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Celsius Therapeutics, Inc. translates single-cell genomic insights into precision therapeutics for autoimmune diseases and cancer. The company was founded by Jeffrey A. Bluestone, Vijay K. Kuchroo, Christoph S. Lengauer, Aviv Regev and Ramnik Xavier in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Founder | |
HotSpot Therapeutics, Inc.
![]() HotSpot Therapeutics, Inc. BiotechnologyHealth Technology HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
CINCOR PHARMA, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
MOMA Therapeutics, Inc.
![]() MOMA Therapeutics, Inc. BiotechnologyHealth Technology MOMA Therapeutics, Inc. operates as a biotechnology firm. The company was founded by Dorothee Kern, Eva Nogales, Johannes Walter, and Timur Yusufzai and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Baltimore Bays Soccer Club | Corporate Officer/Principal | ||
TANGO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
IDRx, Inc.
![]() IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member |
Statistiques
Internationale
Etats-Unis | 37 |
Allemagne | 8 |
Belgique | 3 |
Suisse | 2 |
Israël | 2 |
Sectorielle
Health Technology | 24 |
Consumer Services | 14 |
Finance | 7 |
Commercial Services | 5 |
Consumer Non-Durables | 3 |
Opérationnelle
Director/Board Member | 46 |
Corporate Officer/Principal | 30 |
Independent Dir/Board Member | 15 |
Director of Finance/CFO | 11 |
Chief Tech/Sci/R&D Officer | 9 |
Relations les plus connectées
Insiders | |
---|---|
Graziano Seghezzi | 26 |
Michael Kelly | 19 |
Christoph S. Lengauer | 16 |
Mary Coelho | 12 |
Malte Peters | 11 |
Matthew Beck | 10 |
Igor Matushansky | 7 |
Timothy Reilly | 6 |
Anders Lilja | 4 |
Tony Melckenbeek | 3 |
Nina Waibel | 2 |
Gwenaelle Kerforn | 2 |
- Bourse
- Insiders
- Katia Schlienger
- Connexions Sociétés